BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 3037183)

  • 1. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress on an endogenous digitalislike factor in hypertension.
    Cloix JF; Crabos M; Meyer P
    J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertension.
    Cloix JF; Crabos M; Devynck MA; Elghozi JL; Henning G; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB
    Adv Nephrol Necker Hosp; 1985; 14():161-71. PubMed ID: 2579533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Meyer P
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and clinical studies of endogenous digitalis-like factor in hypertension.
    Cloix JF; Devynck MA; Meyer P
    Ann N Y Acad Sci; 1986; 488():217-27. PubMed ID: 2437846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characterization of an endogenous factor with digitalis-like activity in the heart of the guinea pig (I): Inhibition of Na,K-ATPase)].
    Castañeda Hernández G
    Arch Inst Cardiol Mex; 1987; 57(2):97-101. PubMed ID: 3038043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism by potassium of the inhibition of (Na(+)+K+) ATPase produced by an endogenous digitalis-like compound extracted from mammalian heart.
    Castañeda-Hernández G; Flores-Murrieta FJ
    Arch Med Res; 1992; 23(1):13-7. PubMed ID: 1339224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile salts as endogenous digitalis like factors.
    Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
    Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endogenous Na+, K(+)-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension.
    Tsuda K; Shima H; Takeda J; Kimura K; Nishio I; Masuyama Y
    J Hypertens; 1992 Jul; 10(7):657-61. PubMed ID: 1321193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.